Envoy Medical, Inc. (COCHW) stock
COCHWNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as COCH
$0.03−0.00 (-15.49%)
Close on Oct 30, 2026Market cap $511.80MP/E –Yield –
Envoy Medical operating margin
Operating margin is operating income as a percentage of revenue.
Envoy Medical's operating margin for the twelve months ending Jun 30, 2026 was -11411.1%. For fiscal 2025 it was -9240.7%, against -8558.2% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -9240.7% | −682.4 |
| FY2024 | Dec 31, 2024 | -8558.2% | −2748.4 |
| FY2023 | Dec 31, 2023 | -5809.8% | −2136.4 |
| FY2022 | Dec 31, 2022 | -3673.4% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -10919.6% | −4419.6 |
| Q1 FY2026 | Mar 31, 2026 | -15279.5% | −4177.3 |
| Q4 FY2025 | Dec 31, 2025 | -8513.3% | +2317.6 |
| Q3 FY2025 | Sep 30, 2025 | -13590.5% | −4711.9 |
| Q2 FY2025 | Jun 30, 2025 | -6500.0% | +635.3 |
| Q1 FY2025 | Mar 31, 2025 | -11102.2% | −2824.2 |
| Q4 FY2024 | Dec 31, 2024 | -10831.0% | −3754.1 |
| Q3 FY2024 | Sep 30, 2024 | -8878.6% | −4647.3 |
| Q2 FY2024 | Jun 30, 2024 | -7135.3% | −24.2 |
| Q1 FY2024 | Mar 31, 2024 | -8278.0% | −3443.4 |
| Q4 FY2023 | Dec 31, 2023 | -7076.8% | +7453.2 |
| Q3 FY2023 | Sep 30, 2023 | -4231.3% | −1080.4 |
| Q2 FY2023 | Jun 30, 2023 | -7111.1% | – |
| Q1 FY2023 | Mar 31, 2023 | -4834.6% | – |
| Q4 FY2022 | Dec 31, 2022 | -14530.0% | – |
| Q3 FY2022 | Sep 30, 2022 | -3150.9% | – |